Showing 1 - 10 of 2,006
This note is intended to introduce economists to a simple SIR model of the progression of COVID-19 in the United States over the next 12-18 months. An SIR model is a Markov model of the spread of an epidemic in a population in which the total population is divided into categories of being...
Persistent link: https://www.econbiz.de/10012482048
We assess the economic value of screening testing programs as a policy response to the ongoing COVID-19 pandemic. We find that the fiscal, macroeconomic, and health benefits of rapid SARS-CoV-2 screening testing programs far exceed their costs, with the ratio of economic benefits to costs...
Persistent link: https://www.econbiz.de/10012482250
Persistent link: https://www.econbiz.de/10014340018
Persistent link: https://www.econbiz.de/10012431546
Persistent link: https://www.econbiz.de/10001630802
Persistent link: https://www.econbiz.de/10001637144
Persistent link: https://www.econbiz.de/10001854129
Is the exchange rate or the money growth rate the better instrument of monetary policy? A common argument is that the exchange rate has a natural advantage because it is more transparent: it is easier for the public to monitor than the money growth rate. We formalize this argument in a simple...
Persistent link: https://www.econbiz.de/10013238694
The CDC reports that 1.13 million Americans have died of COVID-19 through June of 2023. I use a model of the impact over the past three years of vaccines and private and public behavior to mitigate disease transmission during the COVID-19 pandemic in the United States to address two questions....
Persistent link: https://www.econbiz.de/10014345630
Persistent link: https://www.econbiz.de/10015189443